Results 1 to 10 of about 1,488 (116)

P1662: STUDY OF THE DEVELOPMENT AND INVOLVEMENT OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN VASCULAR COMPLICATIONS IN LYSOSOMAL DISORDERS

open access: yesHemaSphere, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Irene Serrano-Gonzalo   +4 more
doaj   +2 more sources

P1651: IMPACT OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) AND MACROPHAGE ACTIVATION IN THE THROMBOTIC EVENTS IN COVID-19 PATIENTS

open access: yesHemaSphere, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Irene Serrano-Gonzalo   +8 more
doaj   +2 more sources

Recommendations on the follow‐up of patients with Gaucher disease in Spain: Results from a Delphi survey

open access: yesJIMD Reports, 2023
Management of Gaucher disease (GD) is challenging due to its wide genotypic and phenotypic variability and changing clinical manifestations due to effective treatment.
Pilar Giraldo   +3 more
doaj   +2 more sources

Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease

open access: yesFrontiers in Medicine, 2023
Gaucher disease (GD) is a genetic lysosomal disorder characterized by high bone marrow (BM) involvement and skeletal complications. The pathophysiology of these complications is not fully elucidated.
Esther Valero-Tena   +9 more
doaj   +1 more source

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

open access: yesMovement Disorders, Volume 38, Issue 2, Page 286-303, February 2023., 2023
Abstract Background As gene‐targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated number of subjects with monogenic PD worldwide are currently represented in the literature and availability of
Eva‐Juliane Vollstedt   +306 more
wiley   +1 more source

CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

open access: yesAnnals of Clinical and Translational Neurology, Volume 9, Issue 11, Page 1764-1777, November 2022., 2022
Abstract Background Neuroinflammation has been shown to be an important pathophysiological disease mechanism in frontotemporal dementia (FTD). This includes activation of microglia, a process that can be measured in life through assaying different glia‐derived biomarkers in cerebrospinal fluid. However, only a few studies so far have taken place in FTD,
Ione O. C. Woollacott   +152 more
wiley   +1 more source

Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

open access: yesOrphanet Journal of Rare Diseases, 2023
Background The availability of multiple treatments for type 1 Gaucher disease increases the need for real-life studies to evaluate treatment efficacy and safety and provide clinicians with more information to choose the best personalized therapy for ...
Irene Serrano-Gonzalo   +24 more
doaj   +1 more source

Identification of risk features for complication in Gaucher’s disease patients: a machine learning analysis of the Spanish registry of Gaucher disease

open access: yesOrphanet Journal of Rare Diseases, 2020
Background Since enzyme replacement therapy for Gaucher disease (MIM#230800) has become available, both awareness of and the natural history of the disease have changed.
Marcio M. Andrade-Campos   +9 more
doaj   +1 more source

Enfermedad de Gaucher: una enfermedad multisistémica

open access: yesGalicia Clínica, 2021
La enfermedad de Gaucher es un trastorno autosómico recesivo raro debido a la ausencia de la enzima glucocerebrosidasa, produciéndose acumulación de glucocerebrósidos en el sistema retículo endotelial. Se manifiesta por hepatoesplenomegalia, alteraciones
Alberto Rivera Gallego   +2 more
doaj   +1 more source

Long-read single molecule real-time (SMRT) sequencing of GBA1 locus in Gaucher disease national cohort from Argentina reveals high frequency of complex allele underlying severe skeletal phenotypes: Collaborative study from the Argentine Group for Diagnosis and Treatment of Gaucher Disease

open access: yesMolecular Genetics and Metabolism Reports, 2021
Gaucher disease is renowned for extreme phenotypic diversity that does not show consistent genotype/phenotype correlations. In Argentina, a national collaborative group, Grupo Argentino de Diagnóstico y Tratamiento de la Enfermedad de Gaucher, GADTEG ...
Guillermo I. Drelichman   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy